Sensitization of anoxic mouse tumours to x-rays with diamide and nifuroxime.
D000818:Animals; D001391:Azo Compounds / Q000627:therapeutic use*; D002470:Cell Survival / Q000187:drug effects / Q000528:radiation effects; D002587:Cesium Isotopes; D004305:Dose-Response Relationship, Drug; D004307:Dose-Response Relationship, Radiation; D004359:Drug Therapy, Combination; D005260:Female; D005559:Formamides / Q000031:analogs & derivatives / Q000627:therapeutic use; D007942:Leukemia, Experimental / Q000188:drug therapy / Q000378:metabolism / Q000532:radiotherapy; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000378:metabolism / Q000532:radiotherapy; D051379:Mice; D008807:Mice, Inbred BALB C; D008811:Mice, Inbred DBA; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D009581:Nitrofurans / Q000627:therapeutic use*; D010091:Oximes / Q000627:therapeutic use*; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*; D013438:Sulfhydryl Compounds / Q000378:metabolism; D014965:X-Rays
D001391:Azo Compounds; D002587:Cesium Isotopes; D005559:Formamides; D009581:Nitrofurans; D010091:Oximes; D011838:Radiation-Sensitizing Agents; D013438:Sulfhydryl Compounds